289 related articles for article (PubMed ID: 15794099)
1. [Neuroprotective effects of novel derivatives of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in two brain ischemic models on mice].
Takeda N; Murozono M; Watanabe S; Isshiki A; Watanabe Y
Masui; 2005 Mar; 54(3):240-8. PubMed ID: 15794099
[TBL] [Abstract][Full Text] [Related]
2. Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice.
Ohtaki H; Dohi K; Yofu S; Nakamachi T; Kudo Y; Endo S; Aruga T; Goto N; Watanabe J; Kikuyama S; Shioda S
Regul Pept; 2004 Dec; 123(1-3):61-7. PubMed ID: 15518894
[TBL] [Abstract][Full Text] [Related]
3. Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats.
Tamás A; Reglõdi D; Szántó Z; Borsiczky B; Németh J; Lengvári I
Neuro Endocrinol Lett; 2002 Jun; 23(3):249-54. PubMed ID: 12080287
[TBL] [Abstract][Full Text] [Related]
4. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
[TBL] [Abstract][Full Text] [Related]
5. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.
Delgado M; Martinez C; Pozo D; Calvo JR; Leceta J; Ganea D; Gomariz RP
J Immunol; 1999 Jan; 162(2):1200-5. PubMed ID: 9916753
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus.
Matsuda K; Maruyama K; Nakamachi T; Miura T; Uchiyama M; Shioda S
Peptides; 2005 Sep; 26(9):1611-6. PubMed ID: 16112400
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
[TBL] [Abstract][Full Text] [Related]
9. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
10. PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus.
Nakata M; Kohno D; Shintani N; Nemoto Y; Hashimoto H; Baba A; Yada T
Neurosci Lett; 2004 Nov; 370(2-3):252-6. PubMed ID: 15488333
[TBL] [Abstract][Full Text] [Related]
11. Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals.
Reglodi D; Fábián Z; Tamás A; Lubics A; Szeberényi J; Alexy T; Tóth K; Márton Z; Borsiczky B; Rõth E; Szalontay L; Lengvári I
Regul Pept; 2004 Dec; 123(1-3):51-9. PubMed ID: 15518893
[TBL] [Abstract][Full Text] [Related]
12. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice.
Girard BA; Lelievre V; Braas KM; Razinia T; Vizzard MA; Ioffe Y; El Meskini R; Ronnett GV; Waschek JA; May V
J Neurochem; 2006 Oct; 99(2):499-513. PubMed ID: 17029602
[TBL] [Abstract][Full Text] [Related]
13. Endogenous pituitary adenylate cyclase activating polypeptide is involved in suppression of edema in the ischemic brain.
Nakamachi T; Ohtaki H; Yofu S; Dohi K; Watanabe J; Mori H; Sato A; Hashimoto H; Shintani N; Baba A; Shioda S
Acta Neurochir Suppl; 2010; 106():43-6. PubMed ID: 19812918
[TBL] [Abstract][Full Text] [Related]
14. PACAP promotes neural stem cell proliferation in adult mouse brain.
Mercer A; Rönnholm H; Holmberg J; Lundh H; Heidrich J; Zachrisson O; Ossoinak A; Frisén J; Patrone C
J Neurosci Res; 2004 Apr; 76(2):205-15. PubMed ID: 15048918
[TBL] [Abstract][Full Text] [Related]
15. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
16. Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage.
Stumm R; Kolodziej A; Prinz V; Endres M; Wu DF; Höllt V
J Neurochem; 2007 Nov; 103(4):1666-81. PubMed ID: 17868305
[TBL] [Abstract][Full Text] [Related]
17. Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier.
Nonaka N; Shioda S; Banks WA
Exp Neurol; 2005 Jan; 191(1):137-44. PubMed ID: 15589520
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans.
Warren JB; Cockcroft JR; Larkin SW; Kajekar R; Macrae A; Ghatei MA; Bloom SR
J Cardiovasc Pharmacol; 1992 Jul; 20(1):83-7. PubMed ID: 1383635
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment.
Shioda S; Ohtaki H; Nakamachi T; Dohi K; Watanabe J; Nakajo S; Arata S; Kitamura S; Okuda H; Takenoya F; Kitamura Y
Ann N Y Acad Sci; 2006 Jul; 1070():550-60. PubMed ID: 16888224
[TBL] [Abstract][Full Text] [Related]
20. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
